Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Wall Street in Fives - Must Read Lists for Monday » 16:29
09/20/21
09/20
16:29
09/20/21
16:29
DAL

Delta Air Lines

$40.79 /

+0.69 (+1.72%)

, UAL

United Airlines

$45.27 /

+0.74 (+1.66%)

, AAL

American Airlines

$20.33 /

+0.6 (+3.04%)

, JBLU

JetBlue

$15.51 /

+0.29 (+1.91%)

, LUV

Southwest

$49.58 /

+0.48 (+0.98%)

, ALK

Alaska Air

$56.97 /

+0.03 (+0.05%)

, PFE

Pfizer

$44.22 /

+0.325 (+0.74%)

, BNTX

BioNTech

$339.00 /

-19.75 (-5.51%)

, BRKS

Brooks Automation

$102.56 /

+8.47 (+9.00%)

, TWTR

Twitter

$61.00 /

-1.475 (-2.36%)

, COIN

Coinbase

$236.31 /

-8.88 (-3.62%)

, GM

General Motors

$49.39 /

-1.95 (-3.80%)

, TXN

Texas Instruments

$192.62 /

-3.71 (-1.89%)

, NVS

Novartis

$82.81 /

-0.68 (-0.81%)

, TDC

Teradata

$52.92 /

+2.32 (+4.58%)

, OTLY

Oatly Group

$16.04 /

-0.25 (-1.53%)

, DNA

Ginkgo Bioworks

$11.14 /

-0.945 (-7.82%)

, DIDI

Didi

$7.75 /

-0.545 (-6.57%)

, TRIP

TripAdvisor

$33.07 /

-2.71 (-7.57%)

, FB

Facebook

$355.76 /

-8.79 (-2.41%)

, SYBX

Synlogic

$3.70 /

+0.45 (+13.85%)

, VSTM

Verastem

$2.83 /

+0.075 (+2.72%)

, AMGN

Amgen

$215.17 /

-4.42 (-2.01%)

, SDC

SmileDirectClub

$6.48 /

-0.22 (-3.28%)

, TDOC

Teladoc

$135.48 /

-7.9 (-5.51%)

, WYNN

Wynn Resorts

$82.11 /

-1.21 (-1.45%)

, CGNT

Cognyte

$24.33 /

-3.84 (-13.63%)

, ADGI

Adagio Therapeutics

$46.15 /

-4.85 (-9.51%)

, PSNL

Personalis

$21.29 /

-1.16 (-5.17%)

, MOH

Molina Healthcare

$277.21 /

-1.33 (-0.48%)

, DHI

D.R. Horton

$88.10 /

-2.68 (-2.95%)

, ATVI

Activision Blizzard

$76.20 /

-3.415 (-4.29%)

Get caught up quickly on…

ShowHide Related Items >><<
WYNN Wynn Resorts
$82.11 /

-1.21 (-1.45%)

VSTM Verastem
$2.83 /

+0.075 (+2.72%)

UAL United Airlines
$45.27 /

+0.74 (+1.66%)

TXN Texas Instruments
$192.62 /

-3.71 (-1.89%)

TWTR Twitter
$61.00 /

-1.475 (-2.36%)

TRIP TripAdvisor
$33.07 /

-2.71 (-7.57%)

TDOC Teladoc
$135.48 /

-7.9 (-5.51%)

TDC Teradata
$52.92 /

+2.32 (+4.58%)

SYBX Synlogic
$3.70 /

+0.45 (+13.85%)

SDC SmileDirectClub
$6.48 /

-0.22 (-3.28%)

PSNL Personalis
$21.29 /

-1.16 (-5.17%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

OTLY Oatly Group
$16.04 /

-0.25 (-1.53%)

NVS Novartis
$82.81 /

-0.68 (-0.81%)

MOH Molina Healthcare
$277.21 /

-1.33 (-0.48%)

LUV Southwest
$49.58 /

+0.48 (+0.98%)

JBLU JetBlue
$15.51 /

+0.29 (+1.91%)

GM General Motors
$49.39 /

-1.95 (-3.80%)

FB Facebook
$355.76 /

-8.79 (-2.41%)

DNA Ginkgo Bioworks
$11.14 /

-0.945 (-7.82%)

DIDI Didi
$7.75 /

-0.545 (-6.57%)

DHI D.R. Horton
$88.10 /

-2.68 (-2.95%)

DAL Delta Air Lines
$40.79 /

+0.69 (+1.72%)

COIN Coinbase
$236.31 /

-8.88 (-3.62%)

BRKS Brooks Automation
$102.56 /

+8.47 (+9.00%)

BNTX BioNTech
$339.00 /

-19.75 (-5.51%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

AMGN Amgen
$215.17 /

-4.42 (-2.01%)

ALK Alaska Air
$56.97 /

+0.03 (+0.05%)

ADGI Adagio Therapeutics
$46.15 /

-4.85 (-9.51%)

AAL American Airlines
$20.33 /

+0.6 (+3.04%)

DAL Delta Air Lines
$40.79 /

+0.69 (+1.72%)

08/11/21 Redburn
Delta Air Lines initiated with a Neutral at Redburn
07/15/21 Morgan Stanley
Delta shares deserve to be trading 'significantly higher,' says Morgan Stanley
07/15/21
Fly Intel: Top five analyst upgrades
07/15/21 Susquehanna
Delta Air Lines price target lowered to $45 from $53 at Susquehanna
UAL United Airlines
$45.27 /

+0.74 (+1.66%)

08/11/21 Redburn
United Airlines initiated with a Sell at Redburn
07/22/21 MKM Partners
United Airlines price target lowered to $61 from $65 at MKM Partners
07/22/21 Susquehanna
United Airlines price target lowered to $51 from $56 at Susquehanna
07/13/21
Fly Intel: Top five analyst downgrades
AAL American Airlines
$20.33 /

+0.6 (+3.04%)

08/11/21 Redburn
American Airlines initiated with a Buy at Redburn
07/27/21
Fly Intel: Top five analyst upgrades
07/27/21 Susquehanna
American Airlines upgraded to Neutral at Susquehanna
07/27/21 Susquehanna
American Airlines upgraded to Neutral from Negative at Susquehanna
JBLU JetBlue
$15.51 /

+0.29 (+1.91%)

07/28/21 Susquehanna
JetBlue price target lowered to $21 from $24 at Susquehanna
06/09/21 MKM Partners
JetBlue initiated with a Neutral at MKM Partners
06/09/21 MKM Partners
JetBlue initiated with a Neutral at MKM Partners
04/15/21 Barclays
JetBlue price target raised to $20 from $14 at Barclays
LUV Southwest
$49.58 /

+0.48 (+0.98%)

09/10/21 Evercore ISI
Southwest price target lowered to $62 from $70 at Evercore ISI
08/12/21 Morgan Stanley
Southwest price target lowered to $80 from $85 at Morgan Stanley
08/11/21 Redburn
Southwest initiated with a Buy at Redburn
07/27/21 Berenberg
American Airlines upgraded to Hold from Sell at Berenberg
ALK Alaska Air
$56.97 /

+0.03 (+0.05%)

07/20/21 Raymond James
Alaska Air price target lowered to $78 from $85 at Raymond James
07/12/21 Evercore ISI
Volaris price target raised to $30 from $25 at Evercore ISI
06/18/21 Wolfe Research
Wolfe Research upgrades three airlines on 'pent-up demand scenario'
06/18/21 Wolfe Research
Alaska Air upgraded to Outperform from Peer Perform at Wolfe Research
PFE Pfizer
$44.22 /

+0.325 (+0.74%)

06:31 Today Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
BNTX BioNTech
$339.00 /

-19.75 (-5.51%)

08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
08/20/21 Canaccord
BioNTech price target raised to $450 from $240 at Canaccord
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
BRKS Brooks Automation
$102.56 /

+8.47 (+9.00%)

09/07/21 KeyBanc
Brooks Automation price target raised to $146 from $115 at KeyBanc
05/11/21 Needham
Brooks Automation price target raised to $130 from $110 at Needham
05/11/21 Credit Suisse
Brooks Automation price target raised to $85 from $70 at Credit Suisse
05/11/21 B. Riley
Brooks Automation price target raised to $130 from $125 at B. Riley
TWTR Twitter
$61.00 /

-1.475 (-2.36%)

09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Goldman Sachs
Twitter initiated with a Sell at Goldman Sachs
09/09/21 JPMorgan
Netflix, Uber added as top U.S. Internet picks at JPMorgan
08/23/21 Arete
Arete sees 'various hurdles' for Twitter to hit 2023 sales target
COIN Coinbase
$236.31 /

-8.88 (-3.62%)

09/14/21 Piper Sandler
Coinbase recent selloff overdone, says Piper Sandler
09/08/21 Cowen
SEC's Coinbase action likely a broader crackdown on crypto lending, says Cowen
08/24/21
Fly Intel: Top five analyst initiations
08/24/21 Needham
Coinbase initiated with Buy, $420 price target at Needham
GM General Motors
$49.39 /

-1.95 (-3.80%)

09/13/21 Barclays
General Motors price target lowered to $68 from $71 at Barclays
08/09/21 Jefferies
General Motors price target lowered to $53 from $68 at Jefferies
08/05/21 JPMorgan
GM post-earnings selloff 'seems overblown,' says JPMorgan
08/05/21 Deutsche Bank
General Motors investors should look past headwinds, says Deutsche Bank
TXN Texas Instruments
$192.62 /

-3.71 (-1.89%)

09:55 Today
Fly Intel: Top five analyst downgrades
07:53 Today Longbow
Texas Instruments downgraded to Neutral from Buy at Longbow
07/22/21
Fly Intel: Top five analyst downgrades
07/22/21 Raymond James
Texas Instruments price target raised to $230 from $220 at Raymond James
NVS Novartis
$82.81 /

-0.68 (-0.81%)

04:39 Today Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
TDC Teradata
$52.92 /

+2.32 (+4.58%)

07:27 Today Morgan Stanley
Morgan Stanley ups Teradata to Overweight, says Cloud business underappreciated
06:08 Today Morgan Stanley
Teradata upgraded to Overweight from Equal Weight at Morgan Stanley
09/10/21 JMP Securities
Teradata price target raised to $78 from $70 at JMP Securities
09/08/21 Stifel
Stifel says Parker-Hannifin's Meggitt bid has 'smoother route' with Teradata out
OTLY Oatly Group
$16.04 /

-0.25 (-1.53%)

09:55 Today
Fly Intel: Top five analyst initiations
05:57 Today Citi
Oatly Group initiated with a Buy at Citi
09/10/21 Cowen
Cowen starts Oatly at Outperform, says 'punching above its weight'
09/10/21 Cowen
Oatly Group initiated with an Outperform at Cowen
DNA Ginkgo Bioworks
$11.14 /

-0.945 (-7.82%)

05:39 Today HSBC
Ginkgo Bioworks initiated with a Buy at HSBC
DIDI Didi
$7.75 /

-0.545 (-6.57%)

07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
07/26/21 Atlantic Equities
Atlantic Equities downgrades DiDi to Neutral amid active investigations
07/26/21 Atlantic Equities
DiDi downgraded to Neutral from Overweight at Atlantic Equities
TRIP TripAdvisor
$33.07 /

-2.71 (-7.57%)

10:43 Today BTIG
BTIG says TripAdvisor's reported Plus pivot 'feels like a pretty big concession'
08/18/21 DA Davidson
TripAdvisor price target raised to $48 from $47 at DA Davidson
06/16/21 Truist
TripAdvisor rolls out subscription product 'on schedule,' says Truist
06/14/21 Ascendiant
TripAdvisor price target raised to $54 from $50 at Ascendiant
FB Facebook
$355.76 /

-8.79 (-2.41%)

09/17/21 Jefferies
Facebook price target raised to $440 from $425 at Jefferies
09/13/21 Goldman Sachs
Facebook initiated with a Buy at Goldman Sachs
09/09/21 HSBC
Facebook price target raised to $300 from $275 at HSBC
SYBX Synlogic
$3.70 /

+0.45 (+13.85%)

14:13 Today Chardan
Synlogic phenylketonuria data 'encouraging,' says Chardan
12:15 Today Piper Sandler
Synlogic price target raised to $9 at Piper Sandler on positive SynPHEny data
07/09/21 Chardan
Synlogic assumed with a Buy at Chardan
06/28/21 H.C. Wainwright
Synlogic price target lowered to $9 from $13 at H.C. Wainwright
VSTM Verastem
$2.83 /

+0.075 (+2.72%)

07/01/21 Alliance Global Partners
Verastem initiated with a Buy at Alliance Global Partners
05/24/21 BTIG
Verastem upgraded to Buy from Neutral at BTIG
05/24/21 BTIG
Verastem upgraded to Buy from Neutral at BTIG
AMGN Amgen
$215.17 /

-4.42 (-2.01%)

09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Amgen to Equal Weight, sees better risk/reward elsewhere
09/07/21 Morgan Stanley
Amgen downgraded to Equal Weight from Overweight at Morgan Stanley
08/12/21 Goldman Sachs
Revolution Medicines downgraded to Neutral from Buy at Goldman Sachs
SDC SmileDirectClub
$6.48 /

-0.22 (-3.28%)

08/13/21
Fly Intel: Top five analyst downgrades
08/13/21 Wolfe Research
SmileDirectClub downgraded to Peer Perform from Outperform at Wolfe Research
08/10/21
Fly Intel: Top five analyst downgrades
08/10/21 Loop Capital
SmileDirectClub price target lowered to $6 from $9 at Loop Capital
TDOC Teladoc
$135.48 /

-7.9 (-5.51%)

09:44 Today KeyBanc
New CEO 'certainly a positive surprise' for NextGen shareholders, says KeyBanc
09/15/21 RBC Capital
Teladoc long-term growth outlook intact, says RBC Capital
08/09/21 Cowen
Teladoc price target lowered to $188 from $240 at Cowen
08/02/21
Fly Intel: Top five analyst downgrades
WYNN Wynn Resorts
$82.11 /

-1.21 (-1.45%)

06:59 Today Morgan Stanley
Morgan Stanley cuts Wynn Resorts price target to $113, but says 'worth the risk'
09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
CGNT Cognyte
$24.33 /

-3.84 (-13.63%)

07/27/21 William Blair
Cognyte initiated with an Outperform at William Blair
07/26/21 William Blair
Cognyte initiated with an Outperform at William Blair
03/05/21
Fly Intel: Top five analyst initiations
03/05/21 Evercore ISI
Cognyte initiated with an Outperform at Evercore ISI
ADGI Adagio Therapeutics
$46.15 /

-4.85 (-9.51%)

08/31/21
Fly Intel: Top five analyst initiations
08/31/21 Guggenheim
Adagio Therapeutics initiated with a Buy at Guggenheim
08/31/21 Stifel
Adagio Therapeutics initiated with a Buy at Stifel
08/31/21 Jefferies
Adagio Therapeutics initiated with a Buy at Jefferies
PSNL Personalis
$21.29 /

-1.16 (-5.17%)

06:37 Today Citi
Personalis Veterans Affairs contract smaller than expected, says Citi
08/05/21 Citi
Personalis price target lowered to $30 from $37 at Citi
05/13/21 Truist
Personalis price target lowered to $29 from $37 at Truist
05/06/21 Oppenheimer
Personalis upgraded to Outperform at Oppenheimer on multi-year growth cycle
MOH Molina Healthcare
$277.21 /

-1.33 (-0.48%)

07:28 Today Truist
Molina Healthcare price target raised to $330 from $300 at Truist
07:23 Today Credit Suisse
Molina Healthcare price target raised to $318 from $280 at Credit Suisse
07:21 Today Stephens
Molina Healthcare price target raised to $280 from $260 at Stephens
06:45 Today Mizuho
Molina Healthcare price target raised to $305 from $284 at Mizuho
DHI D.R. Horton
$88.10 /

-2.68 (-2.95%)

07/26/21
Fly Intel: Top five analyst upgrades
07/26/21 Wedbush
D.R. Horton upgraded to Outperform at Wedbush
07/26/21 Wedbush
D.R. Horton upgraded to Outperform from Neutral at Wedbush
07/23/21
Fly Intel: Top five analyst upgrades
ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
WYNN Wynn Resorts
$82.11 /

-1.21 (-1.45%)

VSTM Verastem
$2.83 /

+0.075 (+2.72%)

UAL United Airlines
$45.27 /

+0.74 (+1.66%)

TXN Texas Instruments
$192.62 /

-3.71 (-1.89%)

TWTR Twitter
$61.00 /

-1.475 (-2.36%)

TRIP TripAdvisor
$33.07 /

-2.71 (-7.57%)

TDOC Teladoc
$135.48 /

-7.9 (-5.51%)

TDC Teradata
$52.92 /

+2.32 (+4.58%)

SYBX Synlogic
$3.70 /

+0.45 (+13.85%)

SDC SmileDirectClub
$6.48 /

-0.22 (-3.28%)

PSNL Personalis
$21.29 /

-1.16 (-5.17%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

OTLY Oatly Group
$16.04 /

-0.25 (-1.53%)

NVS Novartis
$82.81 /

-0.68 (-0.81%)

MOH Molina Healthcare
$277.21 /

-1.33 (-0.48%)

LUV Southwest
$49.58 /

+0.48 (+0.98%)

JBLU JetBlue
$15.51 /

+0.29 (+1.91%)

GM General Motors
$49.39 /

-1.95 (-3.80%)

FB Facebook
$355.76 /

-8.79 (-2.41%)

DHI D.R. Horton
$88.10 /

-2.68 (-2.95%)

DAL Delta Air Lines
$40.79 /

+0.69 (+1.72%)

COIN Coinbase
$236.31 /

-8.88 (-3.62%)

CGNT Cognyte
$24.33 /

-3.84 (-13.63%)

BRKS Brooks Automation
$102.56 /

+8.47 (+9.00%)

BNTX BioNTech
$339.00 /

-19.75 (-5.51%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

AMGN Amgen
$215.17 /

-4.42 (-2.01%)

ALK Alaska Air
$56.97 /

+0.03 (+0.05%)

ADGI Adagio Therapeutics
$46.15 /

-4.85 (-9.51%)

AAL American Airlines
$20.33 /

+0.6 (+3.04%)

  • 06
    Aug
  • 30
    Jun
  • 20
    May
  • 16
    Apr
  • 14
    Apr
  • 09
    Feb
  • 27
    Jan
  • 02
    Dec
  • 24
    Nov
  • 19
    Nov
  • 10
    Nov
WYNN Wynn Resorts
$82.11 /

-1.21 (-1.45%)

UAL United Airlines
$45.27 /

+0.74 (+1.66%)

TXN Texas Instruments
$192.62 /

-3.71 (-1.89%)

TWTR Twitter
$61.00 /

-1.475 (-2.36%)

TRIP TripAdvisor
$33.07 /

-2.71 (-7.57%)

TDOC Teladoc
$135.48 /

-7.9 (-5.51%)

SDC SmileDirectClub
$6.48 /

-0.22 (-3.28%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

OTLY Oatly Group
$16.04 /

-0.25 (-1.53%)

NVS Novartis
$82.81 /

-0.68 (-0.81%)

LUV Southwest
$49.58 /

+0.48 (+0.98%)

JBLU JetBlue
$15.51 /

+0.29 (+1.91%)

GM General Motors
$49.39 /

-1.95 (-3.80%)

FB Facebook
$355.76 /

-8.79 (-2.41%)

DIDI Didi
$7.75 /

-0.545 (-6.57%)

DHI D.R. Horton
$88.10 /

-2.68 (-2.95%)

DAL Delta Air Lines
$40.79 /

+0.69 (+1.72%)

COIN Coinbase
$236.31 /

-8.88 (-3.62%)

BRKS Brooks Automation
$102.56 /

+8.47 (+9.00%)

BNTX BioNTech
$339.00 /

-19.75 (-5.51%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

AAL American Airlines
$20.33 /

+0.6 (+3.04%)

WYNN Wynn Resorts
$82.11 /

-1.21 (-1.45%)

VSTM Verastem
$2.83 /

+0.075 (+2.72%)

UAL United Airlines
$45.27 /

+0.74 (+1.66%)

TXN Texas Instruments
$192.62 /

-3.71 (-1.89%)

TWTR Twitter
$61.00 /

-1.475 (-2.36%)

TRIP TripAdvisor
$33.07 /

-2.71 (-7.57%)

TDOC Teladoc
$135.48 /

-7.9 (-5.51%)

TDC Teradata
$52.92 /

+2.32 (+4.58%)

SYBX Synlogic
$3.70 /

+0.45 (+13.85%)

SDC SmileDirectClub
$6.48 /

-0.22 (-3.28%)

PSNL Personalis
$21.29 /

-1.16 (-5.17%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

OTLY Oatly Group
$16.04 /

-0.25 (-1.53%)

NVS Novartis
$82.81 /

-0.68 (-0.81%)

MOH Molina Healthcare
$277.21 /

-1.33 (-0.48%)

LUV Southwest
$49.58 /

+0.48 (+0.98%)

JBLU JetBlue
$15.51 /

+0.29 (+1.91%)

GM General Motors
$49.39 /

-1.95 (-3.80%)

FB Facebook
$355.76 /

-8.79 (-2.41%)

DNA Ginkgo Bioworks
$11.14 /

-0.945 (-7.82%)

DIDI Didi
$7.75 /

-0.545 (-6.57%)

DHI D.R. Horton
$88.10 /

-2.68 (-2.95%)

DAL Delta Air Lines
$40.79 /

+0.69 (+1.72%)

COIN Coinbase
$236.31 /

-8.88 (-3.62%)

CGNT Cognyte
$24.33 /

-3.84 (-13.63%)

BRKS Brooks Automation
$102.56 /

+8.47 (+9.00%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

AMGN Amgen
$215.17 /

-4.42 (-2.01%)

ALK Alaska Air
$56.97 /

+0.03 (+0.05%)

ADGI Adagio Therapeutics
$46.15 /

-4.85 (-9.51%)

AAL American Airlines
$20.33 /

+0.6 (+3.04%)

WYNN Wynn Resorts
$82.11 /

-1.21 (-1.45%)

UAL United Airlines
$45.27 /

+0.74 (+1.66%)

TXN Texas Instruments
$192.62 /

-3.71 (-1.89%)

TWTR Twitter
$61.00 /

-1.475 (-2.36%)

TRIP TripAdvisor
$33.07 /

-2.71 (-7.57%)

TDOC Teladoc
$135.48 /

-7.9 (-5.51%)

TDC Teradata
$52.92 /

+2.32 (+4.58%)

SDC SmileDirectClub
$6.48 /

-0.22 (-3.28%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

OTLY Oatly Group
$16.04 /

-0.25 (-1.53%)

LUV Southwest
$49.58 /

+0.48 (+0.98%)

JBLU JetBlue
$15.51 /

+0.29 (+1.91%)

GM General Motors
$49.39 /

-1.95 (-3.80%)

FB Facebook
$355.76 /

-8.79 (-2.41%)

DNA Ginkgo Bioworks
$11.14 /

-0.945 (-7.82%)

DIDI Didi
$7.75 /

-0.545 (-6.57%)

DHI D.R. Horton
$88.10 /

-2.68 (-2.95%)

DAL Delta Air Lines
$40.79 /

+0.69 (+1.72%)

COIN Coinbase
$236.31 /

-8.88 (-3.62%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

AMGN Amgen
$215.17 /

-4.42 (-2.01%)

AAL American Airlines
$20.33 /

+0.6 (+3.04%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:09
09/20/21
09/20
12:09
09/20/21
12:09
PFE

Pfizer

$44.26 /

+0.37 (+0.84%)

, BNTX

BioNTech

$347.52 /

-11.23 (-3.13%)

, BRKS

Brooks Automation

$101.56 /

+7.47 (+7.94%)

, TWTR

Twitter

$60.03 /

-2.44 (-3.91%)

, DHI

D.R. Horton

$88.03 /

-2.75 (-3.03%)

, COIN

Coinbase

$232.35 /

-12.84 (-5.24%)

, DAL

Delta Air Lines

$40.20 /

+0.1 (+0.25%)

, UAL

United Airlines

$44.68 /

+0.15 (+0.34%)

, JBLU

JetBlue

$15.27 /

+0.045 (+0.30%)

, AAL

American Airlines

$20.06 /

+0.33 (+1.67%)

, LUV

Southwest

$49.00 /

-0.1 (-0.20%)

, ALK

Alaska Air

$56.28 /

-0.66 (-1.16%)

, DIDI

Didi

$7.74 /

-0.55 (-6.63%)

, TRIP

TripAdvisor

$33.56 /

-2.22 (-6.20%)

, FB

Facebook

$353.42 /

-11.13 (-3.05%)

, MDLZ

Mondelez

$60.78 /

-0.17 (-0.28%)

, SYBX

Synlogic

$3.60 /

+0.35 (+10.77%)

, VSTM

Verastem

$2.85 /

+0.09 (+3.27%)

, AMGN

Amgen

$217.14 /

-2.45 (-1.12%)

, SDC

SmileDirectClub

$6.84 /

+0.135 (+2.01%)

, TDOC

Teladoc

$136.96 /

-6.42 (-4.48%)

, EXEL

Exelixis

$19.76 /

-0.975 (-4.70%)

, CGNT

Cognyte

$24.46 /

-3.71 (-13.17%)

, ADGI

Adagio Therapeutics

$49.98 /

-1.02 (-2.00%)

, PSNL

Personalis

$21.52 /

-0.93 (-4.14%)

, MOH

Molina Healthcare

$276.86 /

-1.68 (-0.60%)

, MDGS

Medigus

$1.51 /

+0.03 (+2.03%)

, TXN

Texas Instruments

$191.95 /

-4.38 (-2.23%)

, NVS

Novartis

$83.01 /

-0.48 (-0.57%)

, TDC

Teradata

$52.86 /

+2.26 (+4.47%)

, OTLY

Oatly Group

$16.13 /

-0.16 (-0.98%)

, DNA

Ginkgo Bioworks

$11.24 /

-0.84 (-6.95%)

Get caught up quickly on…

ShowHide Related Items >><<
VSTM Verastem
$2.85 /

+0.09 (+3.27%)

UAL United Airlines
$44.68 /

+0.15 (+0.34%)

TXN Texas Instruments
$191.95 /

-4.38 (-2.23%)

TWTR Twitter
$60.03 /

-2.44 (-3.91%)

TRIP TripAdvisor
$33.56 /

-2.22 (-6.20%)

TDOC Teladoc
$136.96 /

-6.42 (-4.48%)

TDC Teradata
$52.86 /

+2.26 (+4.47%)

SYBX Synlogic
$3.60 /

+0.35 (+10.77%)

SDC SmileDirectClub
$6.84 /

+0.135 (+2.01%)

PSNL Personalis
$21.52 /

-0.93 (-4.14%)

PFE Pfizer
$44.26 /

+0.37 (+0.84%)

OTLY Oatly Group
$16.13 /

-0.16 (-0.98%)

NVS Novartis
$83.01 /

-0.48 (-0.57%)

MOH Molina Healthcare
$276.86 /

-1.68 (-0.60%)

MDLZ Mondelez
$60.78 /

-0.17 (-0.28%)

MDGS Medigus
$1.51 /

+0.03 (+2.03%)

LUV Southwest
$49.00 /

-0.1 (-0.20%)

JBLU JetBlue
$15.27 /

+0.045 (+0.30%)

FB Facebook
$353.42 /

-11.13 (-3.05%)

EXEL Exelixis
$19.76 /

-0.975 (-4.70%)

DNA Ginkgo Bioworks
$11.24 /

-0.84 (-6.95%)

DIDI Didi
$7.74 /

-0.55 (-6.63%)

DHI D.R. Horton
$88.03 /

-2.75 (-3.03%)

DAL Delta Air Lines
$40.20 /

+0.1 (+0.25%)

COIN Coinbase
$232.35 /

-12.84 (-5.24%)

BRKS Brooks Automation
$101.56 /

+7.47 (+7.94%)

BNTX BioNTech
$347.52 /

-11.23 (-3.13%)

AMGN Amgen
$217.14 /

-2.45 (-1.12%)

ALK Alaska Air
$56.28 /

-0.66 (-1.16%)

ADGI Adagio Therapeutics
$49.98 /

-1.02 (-2.00%)

AAL American Airlines
$20.06 /

+0.33 (+1.67%)

PFE Pfizer
$44.26 /

+0.37 (+0.84%)

06:31 Today Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
BNTX BioNTech
$347.52 /

-11.23 (-3.13%)

08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
08/20/21 Canaccord
BioNTech price target raised to $450 from $240 at Canaccord
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
BRKS Brooks Automation
$101.56 /

+7.47 (+7.94%)

09/07/21 KeyBanc
Brooks Automation price target raised to $146 from $115 at KeyBanc
05/11/21 Needham
Brooks Automation price target raised to $130 from $110 at Needham
05/11/21 Credit Suisse
Brooks Automation price target raised to $85 from $70 at Credit Suisse
05/11/21 B. Riley
Brooks Automation price target raised to $130 from $125 at B. Riley
TWTR Twitter
$60.03 /

-2.44 (-3.91%)

09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Goldman Sachs
Twitter initiated with a Sell at Goldman Sachs
09/09/21 JPMorgan
Netflix, Uber added as top U.S. Internet picks at JPMorgan
08/23/21 Arete
Arete sees 'various hurdles' for Twitter to hit 2023 sales target
DHI D.R. Horton
$88.03 /

-2.75 (-3.03%)

07/26/21
Fly Intel: Top five analyst upgrades
07/26/21 Wedbush
D.R. Horton upgraded to Outperform at Wedbush
07/26/21 Wedbush
D.R. Horton upgraded to Outperform from Neutral at Wedbush
07/23/21
Fly Intel: Top five analyst upgrades
COIN Coinbase
$232.35 /

-12.84 (-5.24%)

09/14/21 Piper Sandler
Coinbase recent selloff overdone, says Piper Sandler
09/08/21 Cowen
SEC's Coinbase action likely a broader crackdown on crypto lending, says Cowen
08/24/21
Fly Intel: Top five analyst initiations
08/24/21 Needham
Coinbase initiated with Buy, $420 price target at Needham
DAL Delta Air Lines
$40.20 /

+0.1 (+0.25%)

08/11/21 Redburn
Delta Air Lines initiated with a Neutral at Redburn
07/15/21 Morgan Stanley
Delta shares deserve to be trading 'significantly higher,' says Morgan Stanley
07/15/21
Fly Intel: Top five analyst upgrades
07/15/21 Susquehanna
Delta Air Lines price target lowered to $45 from $53 at Susquehanna
UAL United Airlines
$44.68 /

+0.15 (+0.34%)

08/11/21 Redburn
United Airlines initiated with a Sell at Redburn
07/22/21 MKM Partners
United Airlines price target lowered to $61 from $65 at MKM Partners
07/22/21 Susquehanna
United Airlines price target lowered to $51 from $56 at Susquehanna
07/13/21
Fly Intel: Top five analyst downgrades
JBLU JetBlue
$15.27 /

+0.045 (+0.30%)

07/28/21 Susquehanna
JetBlue price target lowered to $21 from $24 at Susquehanna
06/09/21 MKM Partners
JetBlue initiated with a Neutral at MKM Partners
06/09/21 MKM Partners
JetBlue initiated with a Neutral at MKM Partners
04/15/21 Barclays
JetBlue price target raised to $20 from $14 at Barclays
AAL American Airlines
$20.06 /

+0.33 (+1.67%)

08/11/21 Redburn
American Airlines initiated with a Buy at Redburn
07/27/21
Fly Intel: Top five analyst upgrades
07/27/21 Susquehanna
American Airlines upgraded to Neutral at Susquehanna
07/27/21 Susquehanna
American Airlines upgraded to Neutral from Negative at Susquehanna
LUV Southwest
$49.00 /

-0.1 (-0.20%)

09/10/21 Evercore ISI
Southwest price target lowered to $62 from $70 at Evercore ISI
08/12/21 Morgan Stanley
Southwest price target lowered to $80 from $85 at Morgan Stanley
08/11/21 Redburn
Southwest initiated with a Buy at Redburn
07/27/21 Berenberg
American Airlines upgraded to Hold from Sell at Berenberg
ALK Alaska Air
$56.28 /

-0.66 (-1.16%)

07/20/21 Raymond James
Alaska Air price target lowered to $78 from $85 at Raymond James
07/12/21 Evercore ISI
Volaris price target raised to $30 from $25 at Evercore ISI
06/18/21 Wolfe Research
Wolfe Research upgrades three airlines on 'pent-up demand scenario'
06/18/21 Wolfe Research
Alaska Air upgraded to Outperform from Peer Perform at Wolfe Research
DIDI Didi
$7.74 /

-0.55 (-6.63%)

07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
07/26/21 Atlantic Equities
Atlantic Equities downgrades DiDi to Neutral amid active investigations
07/26/21 Atlantic Equities
DiDi downgraded to Neutral from Overweight at Atlantic Equities
TRIP TripAdvisor
$33.56 /

-2.22 (-6.20%)

10:43 Today BTIG
BTIG says TripAdvisor's reported Plus pivot 'feels like a pretty big concession'
08/18/21 DA Davidson
TripAdvisor price target raised to $48 from $47 at DA Davidson
06/16/21 Truist
TripAdvisor rolls out subscription product 'on schedule,' says Truist
06/14/21 Ascendiant
TripAdvisor price target raised to $54 from $50 at Ascendiant
FB Facebook
$353.42 /

-11.13 (-3.05%)

09/17/21 Jefferies
Facebook price target raised to $440 from $425 at Jefferies
09/13/21 Goldman Sachs
Facebook initiated with a Buy at Goldman Sachs
09/09/21 HSBC
Facebook price target raised to $300 from $275 at HSBC
MDLZ Mondelez
$60.78 /

-0.17 (-0.28%)

07/30/21
Fly Intel: Top five analyst downgrades
07/30/21 Goldman Sachs
Mondelez downgraded to Buy from Conviction Buy at Goldman Sachs
07/19/21 Morgan Stanley
Morgan Stanley equity strategist upgrades Consumer Staples, downgrades Materials
07/19/21 Deutsche Bank
Mondelez price target raised to $71 from $70 at Deutsche Bank
SYBX Synlogic
$3.60 /

+0.35 (+10.77%)

07/09/21 Chardan
Synlogic assumed with a Buy at Chardan
06/28/21 H.C. Wainwright
Synlogic price target lowered to $9 from $13 at H.C. Wainwright
03/25/21 SVB Leerink
Synlogic price target raised to $15 from $10 at SVB Leerink
03/18/21 JonesTrading
Synlogic initiated with a Buy at JonesTrading
VSTM Verastem
$2.85 /

+0.09 (+3.27%)

07/01/21 Alliance Global Partners
Verastem initiated with a Buy at Alliance Global Partners
05/24/21 BTIG
Verastem upgraded to Buy from Neutral at BTIG
05/24/21 BTIG
Verastem upgraded to Buy from Neutral at BTIG
AMGN Amgen
$217.14 /

-2.45 (-1.12%)

09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Amgen to Equal Weight, sees better risk/reward elsewhere
09/07/21 Morgan Stanley
Amgen downgraded to Equal Weight from Overweight at Morgan Stanley
08/12/21 Goldman Sachs
Revolution Medicines downgraded to Neutral from Buy at Goldman Sachs
SDC SmileDirectClub
$6.84 /

+0.135 (+2.01%)

08/13/21
Fly Intel: Top five analyst downgrades
08/13/21 Wolfe Research
SmileDirectClub downgraded to Peer Perform from Outperform at Wolfe Research
08/10/21
Fly Intel: Top five analyst downgrades
08/10/21 Loop Capital
SmileDirectClub price target lowered to $6 from $9 at Loop Capital
TDOC Teladoc
$136.96 /

-6.42 (-4.48%)

09:44 Today KeyBanc
New CEO 'certainly a positive surprise' for NextGen shareholders, says KeyBanc
09/15/21 RBC Capital
Teladoc long-term growth outlook intact, says RBC Capital
08/09/21 Cowen
Teladoc price target lowered to $188 from $240 at Cowen
08/02/21
Fly Intel: Top five analyst downgrades
EXEL Exelixis
$19.76 /

-0.975 (-4.70%)

08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
06/29/21 H.C. Wainwright
Exelixis price target lowered to $35 from $47 at H.C. Wainwright
06/29/21 Oppenheimer
Exelixis price target lowered to $27 from $35 at Oppenheimer
06/28/21 Piper Sandler
Exelixis selloff on trial miss an overreaction, says Piper Sandler
CGNT Cognyte
$24.46 /

-3.71 (-13.17%)

07/27/21 William Blair
Cognyte initiated with an Outperform at William Blair
07/26/21 William Blair
Cognyte initiated with an Outperform at William Blair
03/05/21
Fly Intel: Top five analyst initiations
03/05/21 Evercore ISI
Cognyte initiated with an Outperform at Evercore ISI
ADGI Adagio Therapeutics
$49.98 /

-1.02 (-2.00%)

08/31/21
Fly Intel: Top five analyst initiations
08/31/21 Guggenheim
Adagio Therapeutics initiated with a Buy at Guggenheim
08/31/21 Stifel
Adagio Therapeutics initiated with a Buy at Stifel
08/31/21 Jefferies
Adagio Therapeutics initiated with a Buy at Jefferies
PSNL Personalis
$21.52 /

-0.93 (-4.14%)

06:37 Today Citi
Personalis Veterans Affairs contract smaller than expected, says Citi
08/05/21 Citi
Personalis price target lowered to $30 from $37 at Citi
05/13/21 Truist
Personalis price target lowered to $29 from $37 at Truist
05/06/21 Oppenheimer
Personalis upgraded to Outperform at Oppenheimer on multi-year growth cycle
MOH Molina Healthcare
$276.86 /

-1.68 (-0.60%)

07:28 Today Truist
Molina Healthcare price target raised to $330 from $300 at Truist
07:23 Today Credit Suisse
Molina Healthcare price target raised to $318 from $280 at Credit Suisse
07:21 Today Stephens
Molina Healthcare price target raised to $280 from $260 at Stephens
06:45 Today Mizuho
Molina Healthcare price target raised to $305 from $284 at Mizuho
MDGS Medigus
$1.51 /

+0.03 (+2.03%)

TXN Texas Instruments
$191.95 /

-4.38 (-2.23%)

09:55 Today
Fly Intel: Top five analyst downgrades
07:53 Today Longbow
Texas Instruments downgraded to Neutral from Buy at Longbow
07/22/21
Fly Intel: Top five analyst downgrades
07/22/21 Raymond James
Texas Instruments price target raised to $230 from $220 at Raymond James
NVS Novartis
$83.01 /

-0.48 (-0.57%)

04:39 Today Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
TDC Teradata
$52.86 /

+2.26 (+4.47%)

07:27 Today Morgan Stanley
Morgan Stanley ups Teradata to Overweight, says Cloud business underappreciated
06:08 Today Morgan Stanley
Teradata upgraded to Overweight from Equal Weight at Morgan Stanley
09/10/21 JMP Securities
Teradata price target raised to $78 from $70 at JMP Securities
09/08/21 Stifel
Stifel says Parker-Hannifin's Meggitt bid has 'smoother route' with Teradata out
OTLY Oatly Group
$16.13 /

-0.16 (-0.98%)

09:55 Today
Fly Intel: Top five analyst initiations
05:57 Today Citi
Oatly Group initiated with a Buy at Citi
09/10/21 Cowen
Cowen starts Oatly at Outperform, says 'punching above its weight'
09/10/21 Cowen
Oatly Group initiated with an Outperform at Cowen
DNA Ginkgo Bioworks
$11.24 /

-0.84 (-6.95%)

05:39 Today HSBC
Ginkgo Bioworks initiated with a Buy at HSBC
VSTM Verastem
$2.85 /

+0.09 (+3.27%)

UAL United Airlines
$44.68 /

+0.15 (+0.34%)

TXN Texas Instruments
$191.95 /

-4.38 (-2.23%)

TWTR Twitter
$60.03 /

-2.44 (-3.91%)

TRIP TripAdvisor
$33.56 /

-2.22 (-6.20%)

TDOC Teladoc
$136.96 /

-6.42 (-4.48%)

TDC Teradata
$52.86 /

+2.26 (+4.47%)

SYBX Synlogic
$3.60 /

+0.35 (+10.77%)

SDC SmileDirectClub
$6.84 /

+0.135 (+2.01%)

PSNL Personalis
$21.52 /

-0.93 (-4.14%)

PFE Pfizer
$44.26 /

+0.37 (+0.84%)

OTLY Oatly Group
$16.13 /

-0.16 (-0.98%)

NVS Novartis
$83.01 /

-0.48 (-0.57%)

MOH Molina Healthcare
$276.86 /

-1.68 (-0.60%)

MDLZ Mondelez
$60.78 /

-0.17 (-0.28%)

MDGS Medigus
$1.51 /

+0.03 (+2.03%)

LUV Southwest
$49.00 /

-0.1 (-0.20%)

JBLU JetBlue
$15.27 /

+0.045 (+0.30%)

FB Facebook
$353.42 /

-11.13 (-3.05%)

EXEL Exelixis
$19.76 /

-0.975 (-4.70%)

DHI D.R. Horton
$88.03 /

-2.75 (-3.03%)

DAL Delta Air Lines
$40.20 /

+0.1 (+0.25%)

COIN Coinbase
$232.35 /

-12.84 (-5.24%)

CGNT Cognyte
$24.46 /

-3.71 (-13.17%)

BRKS Brooks Automation
$101.56 /

+7.47 (+7.94%)

BNTX BioNTech
$347.52 /

-11.23 (-3.13%)

AMGN Amgen
$217.14 /

-2.45 (-1.12%)

ALK Alaska Air
$56.28 /

-0.66 (-1.16%)

ADGI Adagio Therapeutics
$49.98 /

-1.02 (-2.00%)

AAL American Airlines
$20.06 /

+0.33 (+1.67%)

  • 06
    Aug
  • 30
    Jun
  • 20
    May
  • 16
    Apr
  • 14
    Apr
  • 27
    Jan
  • 11
    Jan
  • 02
    Dec
  • 02
    Dec
  • 24
    Nov
  • 19
    Nov
  • 10
    Nov
UAL United Airlines
$44.68 /

+0.15 (+0.34%)

TXN Texas Instruments
$191.95 /

-4.38 (-2.23%)

TWTR Twitter
$60.03 /

-2.44 (-3.91%)

TRIP TripAdvisor
$33.56 /

-2.22 (-6.20%)

TDOC Teladoc
$136.96 /

-6.42 (-4.48%)

SDC SmileDirectClub
$6.84 /

+0.135 (+2.01%)

PFE Pfizer
$44.26 /

+0.37 (+0.84%)

OTLY Oatly Group
$16.13 /

-0.16 (-0.98%)

NVS Novartis
$83.01 /

-0.48 (-0.57%)

MDLZ Mondelez
$60.78 /

-0.17 (-0.28%)

LUV Southwest
$49.00 /

-0.1 (-0.20%)

JBLU JetBlue
$15.27 /

+0.045 (+0.30%)

FB Facebook
$353.42 /

-11.13 (-3.05%)

DIDI Didi
$7.74 /

-0.55 (-6.63%)

DHI D.R. Horton
$88.03 /

-2.75 (-3.03%)

DAL Delta Air Lines
$40.20 /

+0.1 (+0.25%)

COIN Coinbase
$232.35 /

-12.84 (-5.24%)

BRKS Brooks Automation
$101.56 /

+7.47 (+7.94%)

BNTX BioNTech
$347.52 /

-11.23 (-3.13%)

AAL American Airlines
$20.06 /

+0.33 (+1.67%)

VSTM Verastem
$2.85 /

+0.09 (+3.27%)

UAL United Airlines
$44.68 /

+0.15 (+0.34%)

TXN Texas Instruments
$191.95 /

-4.38 (-2.23%)

TWTR Twitter
$60.03 /

-2.44 (-3.91%)

TRIP TripAdvisor
$33.56 /

-2.22 (-6.20%)

TDOC Teladoc
$136.96 /

-6.42 (-4.48%)

TDC Teradata
$52.86 /

+2.26 (+4.47%)

SYBX Synlogic
$3.60 /

+0.35 (+10.77%)

SDC SmileDirectClub
$6.84 /

+0.135 (+2.01%)

PSNL Personalis
$21.52 /

-0.93 (-4.14%)

PFE Pfizer
$44.26 /

+0.37 (+0.84%)

OTLY Oatly Group
$16.13 /

-0.16 (-0.98%)

NVS Novartis
$83.01 /

-0.48 (-0.57%)

MOH Molina Healthcare
$276.86 /

-1.68 (-0.60%)

MDLZ Mondelez
$60.78 /

-0.17 (-0.28%)

LUV Southwest
$49.00 /

-0.1 (-0.20%)

JBLU JetBlue
$15.27 /

+0.045 (+0.30%)

FB Facebook
$353.42 /

-11.13 (-3.05%)

EXEL Exelixis
$19.76 /

-0.975 (-4.70%)

DNA Ginkgo Bioworks
$11.24 /

-0.84 (-6.95%)

DIDI Didi
$7.74 /

-0.55 (-6.63%)

DHI D.R. Horton
$88.03 /

-2.75 (-3.03%)

DAL Delta Air Lines
$40.20 /

+0.1 (+0.25%)

COIN Coinbase
$232.35 /

-12.84 (-5.24%)

CGNT Cognyte
$24.46 /

-3.71 (-13.17%)

BRKS Brooks Automation
$101.56 /

+7.47 (+7.94%)

AMGN Amgen
$217.14 /

-2.45 (-1.12%)

ALK Alaska Air
$56.28 /

-0.66 (-1.16%)

ADGI Adagio Therapeutics
$49.98 /

-1.02 (-2.00%)

AAL American Airlines
$20.06 /

+0.33 (+1.67%)

UAL United Airlines
$44.68 /

+0.15 (+0.34%)

TXN Texas Instruments
$191.95 /

-4.38 (-2.23%)

TWTR Twitter
$60.03 /

-2.44 (-3.91%)

TRIP TripAdvisor
$33.56 /

-2.22 (-6.20%)

TDOC Teladoc
$136.96 /

-6.42 (-4.48%)

TDC Teradata
$52.86 /

+2.26 (+4.47%)

SDC SmileDirectClub
$6.84 /

+0.135 (+2.01%)

PFE Pfizer
$44.26 /

+0.37 (+0.84%)

OTLY Oatly Group
$16.13 /

-0.16 (-0.98%)

MDLZ Mondelez
$60.78 /

-0.17 (-0.28%)

LUV Southwest
$49.00 /

-0.1 (-0.20%)

JBLU JetBlue
$15.27 /

+0.045 (+0.30%)

FB Facebook
$353.42 /

-11.13 (-3.05%)

DNA Ginkgo Bioworks
$11.24 /

-0.84 (-6.95%)

DIDI Didi
$7.74 /

-0.55 (-6.63%)

DHI D.R. Horton
$88.03 /

-2.75 (-3.03%)

DAL Delta Air Lines
$40.20 /

+0.1 (+0.25%)

COIN Coinbase
$232.35 /

-12.84 (-5.24%)

AMGN Amgen
$217.14 /

-2.45 (-1.12%)

AAL American Airlines
$20.06 /

+0.33 (+1.67%)

Hot Stocks
AbbVie submits regulatory application to FDA fror risankizumab-rzaa » 09:24
09/20/21
09/20
09:24
09/20/21
09:24
ABBV

AbbVie

$107.75 /

-0.33 (-0.31%)

AbbVie announced that it…

AbbVie announced that it has submitted an application to the U.S. Food and Drug Administration seeking approval for risankizumab-rzaa induction and 360 mg subcutaneous, an interleukin-23 inhibitor, for the treatment of patients 16 years and older with moderate to severe Crohn's disease. The submission is supported by safety and efficacy data from three Phase 3 studies - ADVANCE, MOTIVATE and FORTIFY. In the analysis plans for the U.S. submission of the ADVANCE and MOTIVATE induction studies, a significantly greater proportion of patients with Crohn's disease treated with either dose of risankizumab-rzaa IV induction therapy met the co-primary endpoints of clinical remission and endoscopic response at week 12 compared to placebo. In the analysis plans for the U.S. submission of the FORTIFY trial, a randomized-withdrawal maintenance trial of patients with clinical response to risankizumab-rzaa induction therapy, a significantly greater proportion of participants achieved the co-primary endpoints of endoscopic response and clinical remission with risankizumab-rzaa SC maintenance therapy at one year for both assessed doses, compared to those who were randomized to the withdrawal arm and received placebo SC. The safety profile of all tested doses of risankizumab-rzaa in moderate to severe Crohn's disease in the ADVANCE, MOTIVATE and FORTIFY studies was generally consistent with the known safety profile of risankizumab-rzaa.

ShowHide Related Items >><<
ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

06:31 Today Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

Hot Stocks
Glaukos announces licensing agreement with Attillaps Holdings, no terms » 07:17
09/20/21
09/20
07:17
09/20/21
07:17
GKOS

Glaukos

$53.89 /

+1 (+1.89%)

Glaukos announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GKOS Glaukos
$53.89 /

+1 (+1.89%)

GKOS Glaukos
$53.89 /

+1 (+1.89%)

09/15/21 Piper Sandler
Piper says Glaukos patent settlement doesn't ease reimbursement challenges
09/01/21 William Blair
CMS panel sides with Glaukos on all proposals, says William Blair
08/06/21 Piper Sandler
Glaukos price target lowered to $45 from $80 at Piper Sandler
07/28/21 Citi
Glaukos price target lowered to $52 from $94 at Citi
GKOS Glaukos
$53.89 /

+1 (+1.89%)

GKOS Glaukos
$53.89 /

+1 (+1.89%)

Hot Stocks
Aerie appoints Erik Pacyniak as director, toxicology, drug disposition » 06:39
09/20/21
09/20
06:39
09/20/21
06:39
AERI

Aerie Pharmaceuticals

$12.84 /

+0.495 (+4.01%)

Aerie Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AERI Aerie Pharmaceuticals
$12.84 /

+0.495 (+4.01%)

AERI Aerie Pharmaceuticals
$12.84 /

+0.495 (+4.01%)

11/09/20 H.C. Wainwright
Aerie Pharmaceuticals price target lowered to $29 from $31 at H.C. Wainwright
10/28/20 H.C. Wainwright
Aerie Pharmaceuticals $50M upfront should reduce overhang, says H.C. Wainwright
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
AERI Aerie Pharmaceuticals
$12.84 /

+0.495 (+4.01%)

AERI Aerie Pharmaceuticals
$12.84 /

+0.495 (+4.01%)

Recommendations
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote » 06:31
09/20/21
09/20
06:31
09/20/21
06:31
PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, AZN

AstraZeneca

$55.56 /

-1.04 (-1.84%)

, ABBV

AbbVie

$107.75 /

-0.33 (-0.31%)

, BMY

Bristol-Myers

$61.32 /

+0.1 (+0.16%)

, RHHBY

Roche

$46.07 /

-0.75 (-1.60%)

, NVO

Novo Nordisk

$101.45 /

-0.945 (-0.92%)

, SNY

Sanofi

$48.35 /

+0.14 (+0.29%)

Despite Friday's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$48.35 /

+0.14 (+0.29%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NVO Novo Nordisk
$101.45 /

-0.945 (-0.92%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

09/17/21 Evercore ISI
Innate Pharma price target raised to $10 from $6 at Evercore ISI
09/17/21 Morgan Stanley
AstraZeneca price target raised to 10,000 GBp from 9,800 GBp at Morgan Stanley
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
08/12/21 JPMorgan
AstraZeneca resumed with an Overweight at JPMorgan
ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
09/07/21 Morgan Stanley
Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
RHHBY Roche
$46.07 /

-0.75 (-1.60%)

09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
NVO Novo Nordisk
$101.45 /

-0.945 (-0.92%)

09/03/21 Berenberg
Novo Nordisk price target raised to DKK 530 from DKK 430 at Berenberg
08/23/21 Credit Suisse
Novo Nordisk price target raised to DKK 625 from DKK 470 at Credit Suisse
08/23/21 Citi
Novo Nordisk price target raised to DKK 780 from DKK 510 at Citi
08/17/21 UBS
Novo Nordisk price target raised to DKK 630 from DKK 447 at UBS
SNY Sanofi
$48.35 /

+0.14 (+0.29%)

09/14/21 Mizuho
Kadmon downgraded to Neutral from Buy at Mizuho
09/10/21 UBS
Kadmon downgraded to Neutral from Buy at UBS
09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
SNY Sanofi
$48.35 /

+0.14 (+0.29%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NVO Novo Nordisk
$101.45 /

-0.945 (-0.92%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

SNY Sanofi
$48.35 /

+0.14 (+0.29%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

SNY Sanofi
$48.35 /

+0.14 (+0.29%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NVO Novo Nordisk
$101.45 /

-0.945 (-0.92%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 04:55
09/20/21
09/20
04:55
09/20/21
04:55
ABBV

AbbVie

$107.75 /

-0.33 (-0.31%)

, AYLA

Ayala Pharmaceuticals

$12.25 /

-0.01 (-0.08%)

, DCPH

Deciphera

$33.08 /

+1.45 (+4.58%)

, GMAB

Genmab

$43.10 /

+0.845 (+2.00%)

, LPTX

Leap Therapeutics

$2.65 /

+0.13 (+5.16%)

, ORIC

Oric Pharmaceuticals

$25.20 /

+0.99 (+4.09%)

, SYNH

Syneos Health

$94.34 /

+0.55 (+0.59%)

, BGNE

BeiGene

$403.60 /

+18.32 (+4.75%)

, BMY

Bristol-Myers

$61.32 /

+0.1 (+0.16%)

, BYSI

BeyondSpring

$23.00 /

+0.47 (+2.09%)

, CALA

Calithera Biosciences

$2.25 /

+0.2 (+9.76%)

, GILD

Gilead

$71.61 /

+0.34 (+0.48%)

, GH

Guardant Health

$132.01 /

+5.01 (+3.94%)

, LLY

Eli Lilly

$230.17 /

-0.78 (-0.34%)

, IPSEY

Ipsen

$23.92 /

-0.395 (-1.62%)

, EXAS

Exact Sciences

$108.29 /

+5.47 (+5.32%)

, IDYA

Ideaya Biosciences

$26.90 /

+0.9 (+3.46%)

, GSK

GlaxoSmithKline

$38.94 /

-0.16 (-0.41%)

, RHHBY

Roche

$46.07 /

-0.75 (-1.60%)

, REGN

Regeneron

$651.38 /

-2.3 (-0.35%)

, PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, TAK

Takeda Pharmaceutical

$17.16 /

-0.045 (-0.26%)

, TMO

Thermo Fisher

$596.98 /

+36.11 (+6.44%)

, TCRR

TCR2 Therapeutics

$10.00 /

-5.715 (-36.38%)

, VERU

Veru

$8.94 /

+0.17 (+1.94%)

, VBLT

VBL Therapeutics

$2.32 /

-0.035 (-1.49%)

, VTRS

Viatris

$13.57 /

-0.13 (-0.95%)

, NVS

Novartis

$83.49 /

-0.88 (-1.04%)

ESMO 2021 Virtual…

ESMO 2021 Virtual Congress will be held on September 16-21. Webcast Link

ShowHide Related Items >><<
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
09/07/21 Morgan Stanley
Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with Buy, $29 target at Ladenburg
07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with a Buy at Ladenburg
12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

08/04/21 H.C. Wainwright
Deciphera price target lowered to $70 from $75 at H.C. Wainwright
05/05/21 Barclays
Deciphera price target lowered to $65 from $70 at Barclays
05/05/21 H.C. Wainwright
Deciphera price target lowered to $75 from $80 at H.C. Wainwright
05/05/21 Piper Sandler
Deciphera price target lowered to $60 from $75 at Piper Sandler
GMAB Genmab
$43.10 /

+0.845 (+2.00%)

09/16/21
Fly Intel: Top five analyst downgrades
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Genmab to Underweight amid high investor expectations
LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

09/19/21 Piper Sandler
Piper Sandler keeps Overweight on Leap Therapeutics, ups target to $5
09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

09/08/21 Baird
BeyondSpring initiated with an Outperform at Baird
08/04/21 Evercore ISI
BeyondSpring price target raised to $95 from $30 at Evercore ISI
08/04/21 William Blair
BeyondSpring may have new standard of care in lung cancer, says William Blair
08/04/21 H.C. Wainwright
Wainwright upgrades BeyondSpring with $100 target on lung cancer data
CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
GILD Gilead
$71.61 /

+0.34 (+0.48%)

07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GH Guardant Health
$132.01 /

+5.01 (+3.94%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

08/16/21 Morgan Stanley
Ipsen price target lowered to EUR 88 from EUR 92 at Morgan Stanley
08/03/21 Morgan Stanley
Ipsen price target raised to EUR 92 from EUR 85 at Morgan Stanley
08/02/21 Societe Generale
Ipsen price target raised to EUR 101 from EUR 90 at Societe Generale
07/30/21 Credit Suisse
Ipsen price target raised to EUR 90 from EUR 75 at Credit Suisse
EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/15/21 Canaccord
Exact Sciences progress in MRD space a positive, says Canaccord
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

06/03/21 Baird
Ideaya Biosciences assumed with an Outperform at Baird
04/22/21 Roth Capital
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
04/19/21 H.C. Wainwright
Ideaya Biosciences price target raised to $35 from $29 at H.C. Wainwright
04/16/21 Roth Capital
Ideaya Biosciences price target raised to $31 from $23 at Roth Capital
GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
RHHBY Roche
$46.07 /

-0.75 (-1.60%)

09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
REGN Regeneron
$651.38 /

-2.3 (-0.35%)

09/15/21 Cantor Fitzgerald
Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
09/15/21 H.C. Wainwright
Regeneron price target raised to $831 from $787 at H.C. Wainwright
09/15/21 Piper Sandler
Regeneron price target raised to $690 from $675 at Piper Sandler
09/09/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

08/04/21 Credit Suisse
Thermo Fisher assumed with an Outperform at Credit Suisse
08/04/21 Argus
Thermo Fisher price target raised to $600 from $530 at Argus
07/29/21 Cowen
Thermo Fisher price target raised to $560 from $525 at Cowen
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

09/17/21 Wedbush
TCR2 Therapeutics downgraded to Neutral from Outperform at Wedbush
08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
VERU Veru
$8.94 /

+0.17 (+1.94%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
06/03/21 Roth Capital
Roth Capital ups VBL Therapeutics target to $7 on OVAL primary endpoint update
05/18/21 Guggenheim
VBL Therapeutics initiated with a Buy at Guggenheim
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
NVS Novartis
$83.49 /

-0.88 (-1.04%)

04:39 Today Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

  • 08
    Jul
  • 03
    Jun
  • 04
    May
  • 09
    Apr
  • 01
    Mar
  • 18
    Feb
  • 20
    Jan
  • 02
    Dec
  • 02
    Dec
  • 19
    Nov
  • 13
    Nov
  • 07
    Oct
TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

Downgrade
Novartis downgraded to Sell from Hold at Deutsche Bank » 04:39
09/20/21
09/20
04:39
09/20/21
04:39
NVS

Novartis

$83.49 /

-0.88 (-1.04%)

Deutsche Bank analyst…

Deutsche Bank analyst Emmanuel Papadakis downgraded Novartis to Sell from Hold with a price target of CHF 70, down from CHF 80. The analyst sees "grounds for outright caution near term" with opthalmology looking structurally challenged, pressure set to ramp up for Cosentyx and ongoing weakness in oncology. There are limited reasons to assume a sharp recovery in specialty care in the short term given Covid variant concerns and Novartis' pipeline slate is "thinning," Papadakis tells investors in a research note.

ShowHide Related Items >><<
NVS Novartis
$83.49 /

-0.88 (-1.04%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
NVS Novartis
$83.49 /

-0.88 (-1.04%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

Yesterday
Periodicals
Fauci says key data on J&J, Moderna COVID boosters weeks away, Reuters reports » 15:31
09/19/21
09/19
15:31
09/19/21
15:31
JNJ

Johnson & Johnson

$164.77 /

-0.41 (-0.25%)

, MRNA

Moderna

$429.30 /

-11.54 (-2.62%)

President Joe…

President Joe Biden's chief medical adviser Anthony Fauci said on Sunday that data needed to determine the advisability of booster shots of the Moderna Inc (MRNA) and Johnson & Johnson (JNJ) COVID-19 vaccines is just weeks away, Reuters' Chris Prentice reports. Health officials signaled they expected boosters would ultimately be recommended for a broad swath of the population, but urged Americans not to seek booster doses until they have FDA approval. "We recommend that people wait until you get to the point where you fall into the category where it's recommended," Fauci said. Reference Link

ShowHide Related Items >><<
MRNA Moderna
$429.30 /

-11.54 (-2.62%)

JNJ Johnson & Johnson
$164.77 /

-0.41 (-0.25%)

JNJ Johnson & Johnson
$164.77 /

-0.41 (-0.25%)

09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley downgrades J&J to Equal Weight amid limited mid-term newsflow
MRNA Moderna
$429.30 /

-11.54 (-2.62%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/06/21
Fly Intel: Top five analyst downgrades
MRNA Moderna
$429.30 /

-11.54 (-2.62%)

JNJ Johnson & Johnson
$164.77 /

-0.41 (-0.25%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

JNJ Johnson & Johnson
$164.77 /

-0.41 (-0.25%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

JNJ Johnson & Johnson
$164.77 /

-0.41 (-0.25%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

JNJ Johnson & Johnson
$164.77 /

-0.41 (-0.25%)

Hot Stocks
Novartis announces results of final OS analysis of Phase III MONALEESA-2 study » 09:41
09/19/21
09/19
09:41
09/19/21
09:41
NVS

Novartis

$83.49 /

-0.88 (-1.04%)

Novartis has announced…

Novartis has announced results of the final overall survival analysis of the Phase III MONALEESA-2 study, which evaluated Kisqali in combination with letrozole compared to placebo plus letrozole in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer with no prior systemic treatment for advanced disease. Kisqali in combination with letrozole met its key secondary endpoint of OS, demonstrating a statistically significant and clinically meaningful improvement in survival. The analysis found that after a median follow-up of over six and a half years, the longest for any CDK4/6 inhibitor trial to date, the improvement in the median OS was over one year. MONALEESA-2 showed that after five years, patients treated with Kisqali in combination with letrozole had more than a 50% chance of survival. In MONALEESA-2, a 12-month delay in time to chemotherapy was observed with Kisqali compared to those taking letrozole alone. With this longer follow-up, no new safety signals were observed; adverse events were consistent with previously reported Phase III trial results for Kisqali. In MONALEESA-2, the primary endpoint progression-free survival was met at the initial analysis. These new OS results mark the third statistically significant and clinically meaningful survival benefit achieved by Kisqali in the MONALEESA program. Novartis will submit the data to global health authorities to support label updates.

ShowHide Related Items >><<
NVS Novartis
$83.49 /

-0.88 (-1.04%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
NVS Novartis
$83.49 /

-0.88 (-1.04%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.